Status:
COMPLETED
Cardiac and Lung Assessment of Professional Soccer Players Following COVID-19 Disease
Lead Sponsor:
American Hospital of Paris
Conditions:
Covid19
Eligibility:
All Genders
18-40 years
Brief Summary
During this world COVID-19 outbreak, and according to the experience of team doctors, after their return, some players could have been affected by the SARS-cov2. Also, this study aims to clearly deter...
Detailed Description
The global health crisis caused by the COVID-19 virus, beginning in November 2019, initially in China, has being marked by a rapid spread, numerous severe respiratory cases and an elevated mortality r...
Eligibility Criteria
Inclusion
- Professional soccer player
- age over 18 years
Exclusion
- recent muscle injury (\< 1 month)
- recent orthopedic surgery (\< 3 months)
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04871867
Start Date
September 1 2020
End Date
March 15 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American Hospital of Paris
Neuilly-sur-Seine, France, 92200